Status:
RECRUITING
Metacognitive Therapy for Common Mental Health Problems in Autistic CYP: A Case Series
Lead Sponsor:
University of Manchester
Collaborating Sponsors:
Manchester University NHS Foundation Trust
Pennine Care NHS Foundation Trust
Conditions:
Anxiety
Depression
Eligibility:
All Genders
11-16 years
Phase:
NA
Brief Summary
Anxiety and Depression are common in young people (CYP) and especially in CYP with a diagnosis of Autism. Autistic people often say therapy has not been adapted to meet their needs. A recent treatment...
Detailed Description
This study is a systematic replication case series utilising an AB design with follow up to deliver MCT to autistic CYP who experience symptoms of anxiety and/or depression. Allocation to baseline len...
Eligibility Criteria
Inclusion
- Age between 11-16 years
- Consent given
- Formal diagnosis of Autism Spectrum Disorder
- Fluent in English
- Seeking treatment for emotional disorder symptoms (i.e., generalised anxiety disorder, panic disorder, agoraphobia, post-traumatic stress disorder, obsessive compulsive disorder, social anxiety; and/or depression)
- Medication for mental health problems permitted but participants must be stabilised for 6 weeks
Exclusion
- Presence of significant risk or safeguarding concerns
- Head injury/organic impairment
- Attention Deficit Hyperactivity Disorder (formal diagnosis or under assessment)
- Eating Disorder
Key Trial Info
Start Date :
October 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05980143
Start Date
October 25 2023
End Date
April 1 2024
Last Update
March 28 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, United Kingdom
2
Pennine Care NHS Foundation Trust
Manchester, United Kingdom